Skip to content

A study to understand HbA1c, Blood Pressure, and Lipid control in patients with Type 2 Diabetes Mellitus

A study to understand HbA1c, Blood Pressure and Lipid Control in patients with Type 2 Diabetes Mellitus - TP-DOS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/06/053741
Enrollment
1730
Registered
2023-06-09
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E089- Diabetes mellitus due to underlying condition without complications

Interventions

None listed

Sponsors

Ashish K Saxena
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosed as having T2DM more than 6 months back (HbA1c value >= 6.5% or fasting plasma glucose (>= 126 mg/dL) or 2 hour plasma glucose level of (>= 200 mg/dL) or random plasma glucose of >=200) 2. Taking treatment for Diabetes (Oral glycemic agents or Insulin or both or Lifestyle modification or any other treatment) 3. All aspects of the protocol are explained and written informed consent obtained

Exclusion criteria

Exclusion criteria: 1. Age less than 18 years. 2. Patients who are currently on steroid therapy for any reason or have taken steroids in the last 3 months. Those who have not given their informed consent to participate in the study. Pregnant or lactating females. Serum creatinine >=2mg/dl (180µmol/l) or the presence of any serious concomitant disease limiting life expectancy.

Design outcomes

Primary

MeasureTime frame
To determine the prevalence of meeting risk factor targets of HbA1c, LDL-C and Blood Pressure(BP) among Type II Diabetes Mellitus patients in IndiaTimepoint: 5 years

Secondary

MeasureTime frame
To analyze demographic and clinical parameters associated with achievement of target levels of HbA1C, BP & LDL-C (Profiling of patients)Timepoint: 5 years;To correlate key measures (HbA1C, BP & LDL-C) with BMI, Lifestyle, Social History, Family History and current treatment for T2DMTimepoint: 5 years;To investigate correlations of poor glycemic control with complications of Diabetes (nephropathy, retinopathy, neuropathy, and macrovascular complications)Timepoint: 5 years

Countries

India

Contacts

Public ContactDr Ashish Saxena

Diabetes and Heart Centre

drashishdhc@yahoo.com9023750022

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026